Akari Therapeutics's total assets for Q were $13.83M, an increase of 21.64% from the previous quarter. AKTX total liabilities were $12.04M for the fiscal quarter, a 295.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.